Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DRTS
DRTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DRTS News
Oramed Pharmaceuticals Joins Russell Indexes, Strengthens Financial Position
Jun 25 2026
PRnewswire
First Glioblastoma Patient Treated with Alpha DaRT in Israel
Jun 23 2026
Newsfilter
Alpha Tau Receives FDA Clearance to Expand REGAIN Study
Jun 12 2026
NASDAQ.COM
Alpha Tau Resumes Recruitment for GBM Clinical Trial
Jun 11 2026
Newsfilter
Alpha Tau and Tolmar Form Strategic Collaboration for Prostate Cancer Treatment
Jun 04 2026
NASDAQ.COM
ABIVAX and Others See Significant Stock Gains
Jun 04 2026
NASDAQ.COM
Tolmar Invests $20 Million in Alpha Tau for Prostate Cancer Therapy
Jun 03 2026
stocktwits
Alpha Tau and Tolmar Form Strategic Partnership for Prostate Cancer Treatment
Jun 03 2026
Newsfilter
Positive Results for Alpha DaRT Treatment in Pancreatic Cancer
Jun 01 2026
Newsfilter
Alpha Tau Reports Q1 Loss Exceeding Estimates Amid Clinical Study Updates
May 19 2026
stocktwits
Alpha Tau Medical Reports Wider Q1 Loss and Milestones
May 19 2026
NASDAQ.COM
Alpha Tau Medical Reports Q1 2026 Financial Results
May 18 2026
seekingalpha
Alpha Tau Medical Announces Investor Conference Participation
May 18 2026
Newsfilter
Alpha Tau Medical Reports Promising Trial Results for Glioblastoma Treatment
May 11 2026
stocktwits
Alpha Tau Medical Shares Surge 12% on Positive Glioblastoma Trial Results
May 11 2026
NASDAQ.COM
Trump Rejects Iran's Revised Proposal Amid Geopolitical Tensions
May 11 2026
stocktwits
Show More News
